News

Teva Pharmaceutical Industries Global R&D president and chief scientific officer Michael Hayden said Teva has brought Synribo to the market for patients who need additional treatment options when

New plasmid stability system is designed to achieve plasmid stability throughout the fermentation process by eliminating an essential gene present in the company’s E.coli strains. The essential gene

With the approval, the only once-daily, steroid-containing topical treatment is now indicated for both scalp and body plaque psoriasis for up to eight weeks. Taclonex contains a vitamin

The company began the shipment of the product after winning the final FDA approval. Actos is a prescription medication indicated for type 2 diabetes used along with diet

The firm’s GAAP net income for the third quarter declined to $1.79bn, down from $2.02bn for the same quarter in 2011. Merck’s pharmaceutical sales in the third quarter

Treprostinil is indicated for pulmonary arterial hypertension (PAH) that is at present available in subcutaneous, intravenous, and inhaled forms. The FDA turned down the application and questioned the

In the studies 6-OHDA was primarily injected into the striatum on one side of each rat’s brain, enabling dopaminergic terminals to retract from the striatum towards the substantia

Under the collaboration, Lonza will develop and manufacture demcizumab, anti-Notch 2/3 projects, anti-Fzd7, anti-Notch, anti-DLL4/VEGF Bi-Specific, including many other monoclonal antibodies at its mammalian manufacturing facility in Slough,

As part of the contract, DSM will develop and manufacture Paranta’s lead recombinant human protein, follistatin. The agreement also represents DSM’s collaboration with an Australian customer at their